Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Changes in metabolic syndrome status after initiation of antiretroviral therapy.
Krishnan S, Schouten JT, Atkinson B, Brown TT, Wohl DA, McComsey GA, Glesby MJ, Shikuma C, Haubrich R, Jacobson DL. Krishnan S, et al. Among authors: glesby mj. J Acquir Immune Defic Syndr. 2015 Jan 1;68(1):73-80. doi: 10.1097/QAI.0000000000000397. J Acquir Immune Defic Syndr. 2015. PMID: 25321179 Free PMC article.
Correlation of single photon emission computed tomography parameters as a noninvasive alternative to liver biopsies in assessing liver involvement in the setting of HIV and hepatitis C virus coinfection: a multicenter trial of the Adult AIDS Clinical Trials Group.
Shiramizu B, Theodore D, Bassett R, Coel M, Sherman KE, Glesby MJ, Chow D, Alston B, Colquhoun D, Merigan TC Jr, Reichman RC, Berggren R, Burning WJ, Brobst S; Adult AIDS Clinical Trials Group 5096 Team. Shiramizu B, et al. Among authors: glesby mj. J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):329-35. doi: 10.1097/00126334-200307010-00006. J Acquir Immune Defic Syndr. 2003. PMID: 12843743 Clinical Trial.
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection.
Hendrix CW, Collier AC, Lederman MM, Schols D, Pollard RB, Brown S, Jackson JB, Coombs RW, Glesby MJ, Flexner CW, Bridger GJ, Badel K, MacFarland RT, Henson GW, Calandra G; AMD3100 HIV Study Group. Hendrix CW, et al. Among authors: glesby mj. J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1253-62. doi: 10.1097/01.qai.0000137371.80695.ef. J Acquir Immune Defic Syndr. 2004. PMID: 15385732 Clinical Trial.
Case-control study of diabetes mellitus in HIV-infected patients.
Yoon C, Gulick RM, Hoover DR, Vaamonde CM, Glesby MJ. Yoon C, et al. Among authors: glesby mj. J Acquir Immune Defic Syndr. 2004 Dec 1;37(4):1464-9. doi: 10.1097/01.qai.0000137373.26438.18. J Acquir Immune Defic Syndr. 2004. PMID: 15602124
Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy.
Wohl DA, McComsey G, Tebas P, Brown TT, Glesby MJ, Reeds D, Shikuma C, Mulligan K, Dube M, Wininger D, Huang J, Revuelta M, Currier J, Swindells S, Fichtenbaum C, Basar M, Tungsiripat M, Meyer W, Weihe J, Wanke C. Wohl DA, et al. Among authors: glesby mj. Clin Infect Dis. 2006 Sep 1;43(5):645-53. doi: 10.1086/507333. Epub 2006 Jul 27. Clin Infect Dis. 2006. PMID: 16886161 Review.
204 results